Michael J Jurczak Selected Research

Inflammation (Inflammations)

1/2021	Tregs facilitate obesity and insulin resistance via a Blimp-1/IL-10 axis.
11/2019	Therapeutic Effects of Endogenous Incretin Hormones and Exogenous Incretin-Based Medications in Sepsis.
10/2019	The Role of NADPH Oxidases in the Etiology of Obesity and Metabolic Syndrome: Contribution of Individual Isoforms and Cell Biology.
1/2019	Anti-inflammatory effects of oestrogen mediate the sexual dimorphic response to lipid-induced insulin resistance.
1/2019	The Transcriptional Regulator Id2 Is Critical for Adipose-Resident Regulatory T Cell Differentiation, Survival, and Function.
1/2019	Petite Integration Factor 1 (PIF1) helicase deficiency increases weight gain in Western diet-fed female mice without increased inflammatory markers or decreased glucose clearance.
12/2015	Macrophage-specific de Novo Synthesis of Ceramide Is Dispensable for Inflammasome-driven Inflammation and Insulin Resistance in Obesity.
2/2015	Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes.
2/2012	Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity.
4/2011	Tumor progression locus 2 (TPL2) regulates obesity-associated inflammation and insulin resistance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael J Jurczak Research Topics

Disease

47	Insulin Resistance 01/2022 - 03/2009
22	Obesity 12/2022 - 03/2011
14	Type 2 Diabetes Mellitus (MODY) 01/2022 - 03/2011
10	Inflammation (Inflammations) 01/2021 - 04/2011
9	Weight Gain 01/2019 - 03/2007
8	Body Weight (Weight, Body) 02/2024 - 03/2013
8	Non-alcoholic Fatty Liver Disease 11/2016 - 03/2009
5	Hyperglycemia 01/2022 - 03/2011
4	Neoplasms (Cancer) 01/2023 - 04/2011
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2019 - 02/2012
3	Glucose Intolerance 01/2022 - 03/2011
3	Sepsis (Septicemia) 01/2020 - 10/2019
3	Weight Loss (Weight Reduction) 01/2018 - 07/2010
3	Hyperinsulinism (Hyperinsulinemia) 01/2018 - 07/2014
3	Fatty Liver 01/2018 - 11/2013
3	Hypertriglyceridemia 01/2017 - 03/2009
2	Liver Diseases (Liver Disease) 09/2023 - 01/2019
2	Diabetic Cardiomyopathies 01/2022 - 01/2019
2	Heart Failure 01/2022 - 01/2022
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2020 - 10/2019
2	Critical Illness (Critically Ill) 01/2020 - 11/2019
2	Pneumonia (Pneumonitis) 01/2020 - 10/2019
2	Metabolic Diseases (Metabolic Disease) 10/2019 - 02/2016
2	Necrosis 01/2019 - 02/2012
2	Hypoxia (Hypoxemia) 01/2018 - 05/2015
1	Hemorrhage 02/2024
1	Hepatomegaly 01/2023
1	Neoplasm Metastasis (Metastasis) 01/2023
1	Hypertrophy 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Wounds and Injuries (Trauma) 01/2021
1	Fibrosis (Cirrhosis) 11/2020
1	Cystic Fibrosis (Mucoviscidosis) 01/2020
1	Lung Injury 01/2020
1	Cytokine Release Syndrome 01/2020
1	Systemic Scleroderma (Systemic Sclerosis) 01/2020
1	Hypoglycemia (Reactive Hypoglycemia) 11/2019

Drug/Important Bio-Agent (IBA)

28	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 11/2010
23	LipidsIBA 01/2022 - 12/2010
23	Insulin (Novolin)FDA Link 11/2019 - 03/2009
10	DiglyceridesIBA 11/2019 - 11/2010
8	CytokinesIBA 02/2024 - 11/2011
8	Fatty Acids (Saturated Fatty Acids)IBA 01/2023 - 07/2013
6	CeramidesIBA 11/2019 - 04/2011
4	SodiumIBA 09/2023 - 10/2016
4	Proteins (Proteins, Gene)FDA Link 12/2022 - 01/2012
4	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2019 - 11/2014
4	EnzymesIBA 10/2019 - 01/2012
4	fibroblast growth factor 21IBA 01/2019 - 09/2013
4	Triglycerides (Triacylglycerol)IBA 02/2017 - 07/2010
4	Antisense OligonucleotidesIBA 03/2016 - 01/2013
3	CarbohydratesIBA 02/2024 - 11/2010
3	Oxidoreductases (Dehydrogenase)IBA 01/2022 - 11/2014
3	Blood Glucose (Blood Sugar)IBA 01/2019 - 12/2012
3	Phosphotransferases (Kinase)IBA 01/2018 - 04/2011
3	Insulin ReceptorIBA 11/2016 - 11/2011
3	Tyrosine (L-Tyrosine)FDA Link 01/2012 - 11/2010
2	Pyruvic Acid (Pyruvate)IBA 01/2022 - 11/2014
2	SymportersIBA 01/2022 - 01/2018
2	RNA (Ribonucleic Acid)IBA 11/2020 - 01/2019
2	Protein Isoforms (Isoforms)IBA 10/2019 - 10/2013
2	Estradiol (Delestrogen)FDA LinkGeneric 01/2019 - 03/2013
2	Interleukin-6 (Interleukin 6)IBA 01/2019 - 01/2015
2	Growth Hormone (Somatotropin)IBA 01/2018 - 01/2017
2	Inositol (Myoinositol)IBA 02/2017 - 01/2012
2	Uncoupling AgentsIBA 01/2017 - 11/2013
2	CatalaseIBA 01/2017 - 12/2010
2	Protein Kinase CIBA 11/2016 - 11/2011
2	InflammasomesIBA 12/2015 - 02/2012
2	Acetyl Coenzyme A (Acetyl-CoA)IBA 02/2015 - 11/2014
2	Interleukin-18 (Interleukin 18)IBA 03/2013 - 02/2012
2	Protein Kinases (Protein Kinase)IBA 02/2012 - 04/2011
2	Insulin Receptor Substrate ProteinsIBA 04/2011 - 11/2010
1	CreatineIBA 10/2023
1	Bile Acids and Salts (Bile Acids)IBA 09/2023
1	AldosteroneIBA 09/2023
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2023
1	Growth Differentiation Factor 15IBA 12/2022
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022
1	Lysine (L-Lysine)FDA Link 01/2022
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2022
1	Constitutive Androstane ReceptorIBA 01/2022
1	Benzene (Benzole)IBA 01/2022
1	XenobioticsIBA 01/2022
1	3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-oneIBA 01/2021
1	Interleukin-10 (Interleukin 10)IBA 01/2021
1	UbiquitinIBA 01/2020
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2020
1	Interleukin-3 (Interleukin 3)IBA 01/2020
1	Peptides (Polypeptides)IBA 11/2019
1	Therapeutic UsesIBA 11/2019
1	Hormones (Hormone)IBA 11/2019
1	IncretinsIBA 11/2019
1	Glucagon-Like Peptide 1 (GLP 1)IBA 11/2019
1	NADP (NADPH)IBA 10/2019
1	NADPH Oxidases (NAD(P)H oxidase)IBA 10/2019
1	Xanthine DehydrogenaseIBA 01/2019

Therapy/Procedure

8	Therapeutics 01/2022 - 09/2013
2	Glycemic Control 11/2019 - 01/2018
2	Ketogenic Diet 09/2015 - 11/2010